Cargando…
Microbial bile salt hydrolases mediate the efficacy of faecal microbiota transplant in the treatment of recurrent Clostridioides difficile infection
OBJECTIVE: Faecal microbiota transplant (FMT) effectively treats recurrent Clostridioides difficile infection (rCDI), but its mechanisms of action remain poorly defined. Certain bile acids affect C. difficile germination or vegetative growth. We hypothesised that loss of gut microbiota-derived bile...
Autores principales: | Mullish, Benjamin H, McDonald, Julie A K, Pechlivanis, Alexandros, Allegretti, Jessica R, Kao, Dina, Barker, Grace F, Kapila, Diya, Petrof, Elaine O, Joyce, Susan A, Gahan, Cormac G M, Glegola-Madejska, Izabela, Williams, Horace R T, Holmes, Elaine, Clarke, Thomas B, Thursz, Mark R, Marchesi, Julian R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6839797/ https://www.ncbi.nlm.nih.gov/pubmed/30816855 http://dx.doi.org/10.1136/gutjnl-2018-317842 |
Ejemplares similares
-
Bacteriophage transfer during faecal microbiota transplantation in Clostridium difficile infection is associated with treatment outcome
por: Zuo, Tao, et al.
Publicado: (2018) -
Faecal microbiota transplantation: applications and limitations in treating gastrointestinal disorders
por: Sbahi, Hani, et al.
Publicado: (2016) -
A novel faecal Lachnoclostridium marker for the non-invasive diagnosis of colorectal adenoma and cancer
por: Liang, Jessie Qiaoyi, et al.
Publicado: (2020) -
Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study
por: El-Salhy, Magdy, et al.
Publicado: (2020) -
Faecal microbiota transplantation halts progression of human new-onset type 1 diabetes in a randomised controlled trial
por: de Groot, Pieter, et al.
Publicado: (2021)